Safety and Efficacy of Remote Ischemic Conditioning in Patients With Essential Hypertension (SERIC-EH)
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Essential Hypertension (SERIC-EH)
ClinicalTrials.gov ID: NCT03945305
Sponsor: Yi Yang
Information provided by: Yi Yang, The First Hospital of Jilin University (Responsible Party)
Last Update Posted: 2022-11-02
Brief Summary:
The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning for essential hypertension.
Detailed Description:
In this study, 1000 cases of essential hypertension in changping district, Beijing, who are currently taking oral antihypertensive drugs and still have poor blood pressure control (> 130/80mmHg) are included. The duration of the study is 3+ (30±2) days, during which time the changing of antihypertensive drugs are avoided and the types and doses of drugs taken daily are recorded. Baseline blood pressure and heart rate are measured 2 times a day for 3 days. And then the blood pressure and heart rate are measured before and after remote ischemic conditioning for 200mmHg, twice a day, 30±2 days in a row to evaluate the efficacy and safety of remote ischemic conditioning on essential hypertension.
Official Title:
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Essential Hypertension
Intervention / Treatment:
Device: Remote Ischemic Conditioning
| Category | Value |
|---|---|
| Study Start (Actual) | 2023-01-03 |
| Primary Completion (Estimated) | 2025-07-31 |
| Study Completion (Estimated) | 2025-07-31 |
| Enrollment (Estimated) | 1000 |
| Study Type | Interventional |
| Phase | Not Applicable |
| Other Study ID Numbers |
SERIC-EH |